医药板块阶段震荡分化、轮动加快，建议把握主题轮动及底部调整机会，尤其是创新药及产业链。本周沪深300 指数上涨1.28%，医药生物下跌0.74%，处于31个一级子行业第21 位。12 月第一周，医药板块内部出现了明显的分化，医药商业、中药分别上涨5.19%、0.03%；医疗器械、生物制品、化学制药、医疗服务分别下跌0.93%、1.28%、1.14%、1.37%。一方面，受流感高发等因素刺激，医药...
Source Link医药板块阶段震荡分化、轮动加快，建议把握主题轮动及底部调整机会，尤其是创新药及产业链。本周沪深300 指数上涨1.28%，医药生物下跌0.74%，处于31个一级子行业第21 位。12 月第一周，医药板块内部出现了明显的分化，医药商业、中药分别上涨5.19%、0.03%；医疗器械、生物制品、化学制药、医疗服务分别下跌0.93%、1.28%、1.14%、1.37%。一方面，受流感高发等因素刺激，医药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.